Y-Mabs Therapeutics Inc

NASDAQ:YMAB   4:00:00 PM EDT
4.51
-0.19 (-4.04%)
4:12:53 PM EDT: $4.73 +0.22 (+4.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)204.29M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.37 Million
Adjusted EPS-$0.26
See more estimates
10-Day MA$4.74
50-Day MA$4.47
200-Day MA$7.99
See more pivots

Y-Mabs Therapeutics Inc Stock, NASDAQ:YMAB

202 Carnegie Center, Suite 301, Princeton, New Jersey 08540
United States of America
Phone: +1.646.885.8505
Number of Employees: 107

Description

Y-mAbs Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of antibody based therapeutic products for the treatment of cancer. Its services include discovery, protein engineering, clinical and regulatory. Y-mAbs Therapeutics was founded by Thomas Gad in April 2015 and is headquartered in Princeton, NJ.